Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
Division of Dermatology, Okazaki City Hospital, Okazaki, Japan.
E
E
Tomida
Division of Dermatology, Okazaki City Hospital, Okazaki, Japan.
Y
Y
Kato
Division of Pathology, Okazaki City Hospital, Okazaki, Japan.
H
H
Ozawa
Division of Surgery, Okazaki City Hospital, Okazaki, Japan.
H
H
Hasegawa
Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
N
N
Ishii
Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.
T
T
Hashimoto
Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan. makiyama@med.nagoya-u.ac.jp.
M
M
Akiyama
D000368:Aged; D000667:Ampicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004338:Drug Combinations; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D062027:Linear IgA Bullous Dermatosis / Q000139:chemically induced* / Q000175:diagnosis; D008213:Lymphocyte Activation / Q000187:drug effects*; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D010878:Piperacillin / Q000009:adverse effects; D013407:Sulbactam / Q000009:adverse effects; D000078142:Tazobactam
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D000667:Ampicillin; D010397:Penicillanic Acid; D013407:Sulbactam; D000078142:Tazobactam; D010878:Piperacillin